Listed

Lakefront Biotherapeutics NV: Form 20-F for the period ended Dec 31, 2025

Filed with the SEC on Mar 26, 2026 and accepted by EDGAR at Mar 26, 2026, 16:02 ET.

Share

Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2025-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue12 months2025-01-01 to 2025-12-31EUR 1.11bnifrs-full:Revenue
Cost of revenue12 months2025-01-01 to 2025-12-31EUR 29.7mifrs-full:CostOfSales
Operating income12 months2025-01-01 to 2025-12-31EUR 295.0mifrs-full:ProfitLossFromOperatingActivities
Income tax12 months2025-01-01 to 2025-12-31−EUR 18.6mifrs-full:IncomeTaxExpenseContinuingOperations
Net income12 months2025-01-01 to 2025-12-31EUR 320.9mifrs-full:ProfitLossAttributableToOwnersOfParent
Diluted EPS12 months2025-01-01 to 2025-12-31EUR 4.87ifrs-full:DilutedEarningsLossPerShare
Basic EPS12 months2025-01-01 to 2025-12-31EUR 4.87ifrs-full:BasicEarningsLossPerShare
Operating cash flow12 months2025-01-01 to 2025-12-31−EUR 257.5mifrs-full:CashFlowsFromUsedInOperatingActivities
Capital expenditure12 months2025-01-01 to 2025-12-31EUR 13.7mifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities
Cash and equivalentsAt period end2025-12-31$40.0mifrs-full:CashAndCashEquivalents
Current assetsAt period end2025-12-31EUR 3.08bnifrs-full:CurrentAssets
Total assetsAt period end2025-12-31EUR 3.41bnifrs-full:Assets
Current liabilitiesAt period end2025-12-31EUR 152.9mifrs-full:CurrentLiabilities
Total liabilitiesAt period end2025-12-31EUR 170.7mifrs-full:Liabilities
Shareholders' equityAt period end2025-12-31EUR 3.24bnifrs-full:Equity
Shares outstandingAt period end2025-12-3165,897,071 sharesdei:EntityCommonStockSharesOutstanding

Source: SEC EDGAR, the filing index for accession 0001104659-26-035163. Last ingested by Listed: Nov 12, 2026, 17:23 ET. Listed shows no prices and gives no investment advice.